Abstract
S689 Fiber, Antispasmodics, and Laxatives Remain the Mainstay of IBS Treatment: A Potential Consequence of Weak Guideline Recommendations, Time Constraints, and High Drug Costs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have